Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1982 Jun;76(2):319–326. doi: 10.1111/j.1476-5381.1982.tb09223.x

Effect of sulphasalazine on pulmonary inactivation of prostaglandin F2 alpha in the pig.

P G Hellewell, J D Pearson
PMCID: PMC2071779  PMID: 6178459

Abstract

1 The metabolism of prostaglandin F2 alpha (PGF2 alpha) 15 nm in 100,000 g supernatant fractions from piglet lung homogenates was inhibited by sulphasalazine with an IC50 value of 25 micrometers. 2 The piglet isolated lung perfused with Krebs solution, containing either albumin or Ficoll 70 to prevent oedema and vascular damage, efficiently metabolized PGF2 alpha given as a bolus injection (1 ng in 0.1 ml; 30 nm). 3 In Krebs solution containing Ficoll 70, sulphasalazine inhibited the pulmonary inactivation of PGF2 alpha in a dose-dependent manner with an IC50 value of 110 micrometers. No inhibition of inactivation by sulphasalazine was found when the perfusion fluid contained albumin, which is known to bind this drug effectively. 4 Analysis of the separated efflux profiles for PGF2 alpha and its metabolites with reference to the dilution curve for an extracellular marker provided evidence that sulphasalazine inhibited PGF2 alpha uptake into lung cells. 5 We conclude that the effect of sulphasalazine on pulmonary prostaglandin inactivation is primarily due to inhibition of prostaglandin transport, and not to inhibition of prostaglandin metabolism.

Full text

PDF
319

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ager A., Gordon J. L., Moncada S., Pearson J. D., Salmon J. A., Trevethick M. A. Effects of isolation and culture on prostaglandin synthesis by porcine aortic endothelial and smooth muscle cells. J Cell Physiol. 1982 Jan;110(1):9–16. doi: 10.1002/jcp.1041100103. [DOI] [PubMed] [Google Scholar]
  2. Alabaster V. A., Bakhle Y. S. Removal of 5-hydroxytryptamine in the pulmonary circulation of rat isolated lungs. Br J Pharmacol. 1970 Nov;40(3):468–482. [PMC free article] [PubMed] [Google Scholar]
  3. Anders N. H. Preparative thin-layer and column chromatography of prostaglandins. J Lipid Res. 1969 May;10(3):316–319. [PubMed] [Google Scholar]
  4. Anderson M. W., Eling T. E. Prostaglandin removal and metabolism by isolated perfused rat lung. Prostaglandins. 1976 Apr;11(4):645–677. doi: 10.1016/0090-6980(76)90067-8. [DOI] [PubMed] [Google Scholar]
  5. Anggard E., Oliw E. Formation and degradation of prostaglandins in the lung. Agents Actions. 1976 Jul;6(4):498–504. doi: 10.1007/BF01973268. [DOI] [PubMed] [Google Scholar]
  6. Bakhle Y. S. Action of prostaglandin dehydrogenase inhibitors on prostaglandin uptake in rat isolated lung. Br J Pharmacol. 1979 Apr;65(4):635–639. doi: 10.1111/j.1476-5381.1979.tb07875.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bakhle Y. S. Effects of sulphasalazine on prostaglandin inactivation and synthesis in isolated lungs of guinea pig, rat and man. Eur J Pharmacol. 1980 Dec 19;68(4):493–496. doi: 10.1016/0014-2999(80)90425-2. [DOI] [PubMed] [Google Scholar]
  8. Bito L. Z., Baroody R. A. Inhibition of pulmonary prostaglandin metabolism by inhibitors of prostaglandin biotransport (probenecid and bromcresol green). Prostaglandins. 1975 Oct;10(4):633–639. doi: 10.1016/s0090-6980(75)80010-4. [DOI] [PubMed] [Google Scholar]
  9. Crutchley D. J., Piper P. J. Prostaglandin inactivation in guinea-pig lung and its inhibition. Br J Pharmacol. 1974 Oct;52(2):197–203. doi: 10.1111/j.1476-5381.1974.tb09700.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dawson C. A., Cozzini B. O., Lonigro A. J. Metabolism of [2-14C]prostaglandin E1 on passage through the pulmonary circulation. Can J Physiol Pharmacol. 1975 Aug;53(4):610–615. doi: 10.1139/y75-085. [DOI] [PubMed] [Google Scholar]
  11. Eling T. E., Hawkins H. J., Anderson M. W. Structural requirements for, and the effects of chemicals on, the rat pulmonary inactivation of prostaglandins. Prostaglandins. 1977 Jul;14(1):51–60. doi: 10.1016/0090-6980(77)90156-3. [DOI] [PubMed] [Google Scholar]
  12. Hawkins H. J., Wilson A. G., Anderson M. W., Eling T. E. Uptake and metabolism of prostaglandins by isolated perfused lung: species comparisons and the role of plasma protein binding. Prostaglandins. 1977 Aug;14(2):251–259. doi: 10.1016/0090-6980(77)90170-8. [DOI] [PubMed] [Google Scholar]
  13. Hoult J. R., Moore P. K. Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle. Br J Pharmacol. 1980 Apr;68(4):719–730. doi: 10.1111/j.1476-5381.1980.tb10865.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hoult J. R., Moore P. K. Pathways of prostaglandin F2alpha metabolism in mammalian kidneys. Br J Pharmacol. 1977 Dec;61(4):615–626. doi: 10.1111/j.1476-5381.1977.tb07555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hoult J. R., Moore P. K. Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis. Br J Pharmacol. 1978 Sep;64(1):6–8. doi: 10.1111/j.1476-5381.1978.tb08633.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jansen J. A. Kinetics of the binding of salicylazosulfapyridine to human serum albumin. Acta Pharmacol Toxicol (Copenh) 1977 Nov;41(5):401–416. doi: 10.1111/j.1600-0773.1977.tb02151.x. [DOI] [PubMed] [Google Scholar]
  17. Linehan J. H., Dawson C. A. A kinetic model of prostaglandin metabolism in the lung. J Appl Physiol Respir Environ Exerc Physiol. 1979 Aug;47(2):404–411. doi: 10.1152/jappl.1979.47.2.404. [DOI] [PubMed] [Google Scholar]
  18. Linehan J. H., Dawson C. A., Wagner-Weber V. M. Prostaglandin E1 uptake by isolated cat lungs perfused with physiological salt solution. J Appl Physiol Respir Environ Exerc Physiol. 1981 Feb;50(2):428–434. doi: 10.1152/jappl.1981.50.2.428. [DOI] [PubMed] [Google Scholar]
  19. Ody C., Dieterle Y., Wand I., Stalder H., Junod A. F. PGA1 and PGF2 alpha metabolism by pig pulmonary endothelium, smooth muscle, and fibroblasts. J Appl Physiol Respir Environ Exerc Physiol. 1979 Feb;46(2):211–216. doi: 10.1152/jappl.1979.46.2.211. [DOI] [PubMed] [Google Scholar]
  20. Raz A. Interaction of prostaglandins with blood plasma proteins. Comparative binding of prostaglandins A 2 , F 2 and E 2 to human plasma proteins. Biochem J. 1972 Nov;130(2):631–636. doi: 10.1042/bj1300631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rickaby D. A., Linehan J. H., Bronikowski T. A., Dawson C. A. Kinetics of serotonin uptake in the dog lung. J Appl Physiol Respir Environ Exerc Physiol. 1981 Aug;51(2):405–414. doi: 10.1152/jappl.1981.51.2.405. [DOI] [PubMed] [Google Scholar]
  22. Robinson C., Hoult J. R. Inactivation of prostaglandins in the perfused rat lung. Biochem Pharmacol. 1982 Mar 1;31(5):633–638. doi: 10.1016/0006-2952(82)90442-7. [DOI] [PubMed] [Google Scholar]
  23. Trevethick M. A., Olverman H. J., Pearson J. D., Gordon J. L., Lyles G. A., Callingham B. A. Monoamine oxidase activities of porcine vascular endothelial and smooth muscle cells. Biochem Pharmacol. 1981 Aug 15;30(16):2209–2216. doi: 10.1016/0006-2952(81)90089-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES